The electrocardiogram refers to a graph that shows the heart is excited by the pacing point, the atrium, and the ventricle successively in each cardiac cycle. With changes in the electrocardiogram bioelectricity, various forms of potential replacements drawn from the body surface through the electrocardiograph. An electrocardiogram is an objective indicator of the occurrence, transmission, and recovery of cardiac excitement.
It used to check a variety of arrhythmias, ventricular atrial hypertrophy, myocardial infarction, abnormal heart rate, myocardial ischemia, electrolyte imbalance (the clinical reference significance of rapid direct observation of unusual changes in blood potassium), heart failure and other diseases.
The global Diagnostic ECG market expected to propel the substantial rise in CAGR in the forecast period from 2020-2027. Due to the changing lifestyle of the people, increasing cardiovascular diseases, advancement in technology, and wireless monitoring and wearable devices has fueled the market share of the global diagnostic ECG market.
Moreover, the ECG market has shown a splendid growth in recent years and expected to boost in the forecast period owing to the increasing geriatric population and with bolstering health facilities. Infrastructure has boomed the market share for the diagnostic ECG market.
Additionally, ECG recommended to patients to diagnoses before and after the heartbeats, the myocardium becomes agitated, and during the agitation process, a weak biological current generated. Each cardiac cycle of the heart is accompanied by changes in bioelectricity, which is transmitted to various parts of the body surface. Due to different tissues of the body, and distance from the heart, the electrical potential of the ECG signal in different parts of the body, is also different.
For a healthy heart, the direction, frequency, and intensity of this bioelectrical change are regular. Electrodes detect the electrical signals of different parts of the body surface, then amplified by an amplifier, and recorded by a recorder to obtain an electrocardiogram pattern. Doctors can diagnose heart disease based on the recorded ECG waveform shape, amplitude, and relative time relationship between the waves, compared with normal ECG.
The increasing geriatric population coupled with unhealthy eating, obesity, and non-maintenance of work-life balance has contributed to the rising cases of cardiovascular diseases. Therefore, rising cardiovascular diseases have appeared in the market of the ECG diagnostic market. ECG diagnosis the heart structure and abnormality in its working, such as myocardial infarction, enlargement, and hypertrophic heart, and other heart-related diseases.
The disposable income of the country has positively affected the health infrastructure of the states. Along with it, the advancement in technology has improved medical treatment and thus helps in providing better and affordable treatment to every section of society.
Based on Product, the global diagnostic ECG market segmented into Resting ECG, Stress, Mobile Cardiac Telemetry Device, Implantable Loop Recorder. The resting ECG segment will bolster the market share for the global diagnostic ECG market and will continue to propel the market demand in the forecast period from 2020-2027. The resting ECG is a rapid, simple, and painless test, and it does not require any preparation for the test. It can easily detect sequelae of myocardial infarction, hypertrophy of heart, ischemia, and other abnormal dysfunction of the heart.
Moreover, implantable loop recorders will also emerge its market demand in the future owing to cost-effectiveness, take a short time in diagnosis. Therefore, ILR will further spur the market growth of the ECG diagnostic market.
Based on the application, the global diagnostic ECG market classified into12-lead, three lead, 6-lead, 5- lead. The 3-lead segment has dominated the demand of the global diagnostic ECG market and will continue to boost in the forecast period. Two electrodes placed on the limb, and they measured in pairs (such as the left arm electrode (LA), right arm electrode (RA), and left leg electrode (LL)): LA + RA, LA + LL, RA + LL). The output signal of each electrode pair is called a set of leads. The lead is to look at the changes in cardiac current from different angles. 3-lead ECGs mostly used in situations require continuous monitoring of ECG activity through a monitor, such as during surgery or in surveillance when an ambulance is transporting a patient.
Three-lead is used for rapid positioning and replacement of electrodes when using a dynamic electrocardiogram. Its structure includes a patch body. The patch body provided with the REF pole, V1 pole, V3 pole, and V5 pole, and the REF pole, V1 pole, V3 pole, and V5 pole are respectively connected to the lower part of the patch body by a wire. Flexible cable. Also, it has the characteristics of flexible design, simple structure, convenient use, and high diagnostic accuracy.
Based on end-users, the global diagnostic ECG market distributed into Hospitals, clinics, & cardiac care centers, ambulatory surgical centers, and other end users. The hospitals, clinics & cardiac care centers have captured the largest market share of the global diagnostic ECG market. With increasing cases of cardiovascular diseases, good quality of diagnostic equipment required by the hospitals. Therefore, growing patients visits to the physician and cardiologist will help in fueling the demand for the global diagnostic market.
Based on geography, the global diagnostic ECG market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. The North American region has dominated the demand of the global diagnostic ECG market. Owing to emerging technology, rising disposable income, and advanced healthcare and infrastructure facilities have propelled the need for the ECG diagnostic market. Moreover, the growing population geriatric population and increasing obesity among them have emerged the cardiovascular diseases. Therefore, the global ECG diagnostic market demand will anticipate the highest share in the forecast period.
Companies such as GE Healthcare, Nihon Kohden Corporation, Koninklijke Philips, Medtronic, Hill-Rom Holdings, SCHILLER, BioTelemetry, Inc., BPL Medical Technologies, ACS Diagnostics, SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS Co., Ltd., BTL, Ambu A/S, Allengers Medical Systems, Ltd., FUKUDA DENSHI, Innomed Medical, Edan Instruments, Inc., Cardioline SpA, Eccosur, SUZUKEN Co., Ltd., Norav Medical, VectraCor, Inc., Bionet Co., Ltd., Nexus Lifecare, Midmark Corporation, OSI Systems, Inc. and others are the key players in global diagnostic ECG market.